Spring 2017 Vol. 07 Issue 01
-
From the Editor-in-Chief
Palliative Care: Putting a Cloak on CancerPatients should have access to this vital and emerging medical specialty.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
How Much Do You Want to Share?Determining what to tell people about your cancer requires careful thought.
by Hester Hill Schnipper
-
Caregiving With Confidence
In for the Long HaulWhen cancer becomes a chronic condition, caregiving requires adjusting to a new normal.
by Aimee Swartz
-
A Prescription for Prevention?
Scientists are working to understand the molecular processes that transform normal cells into cancer cells in the hope they can prevent the disease before it starts.
by Marci A. Landsmann
-
Seeking a Second Opinion
Another perspective on your disease may help you find the best cancer care.
by Stephen Ornes
-
Survivor Profile
Putting Her Armor OnAn acute myeloid leukemia survivor and former TV news reporter finds a new reason to help others improve their health.
by Jennifer Walker
-
Yesterday & Today
TV’s Family ManMichael Landon, best known for his roles on Little House on the Prairie and Bonanza, created and starred in programs that portrayed family values with authenticity and humor.
by Marci A. Landsmann
-
Q&A
Rolling Up Her SleevesPrincess Dina Mired of Jordan will be the first Arab president of the Union for International Cancer Control.
by Sue Rochman
-
Sound Advice
Your Questions, Our Answers – Spring 2017The sugar-feeds-cancer myth, talking to a friend with cancer, and facing down "scanxiety."
-
Get Involved
Outdoor HealingAn outdoor adventure camp benefits cancer survivors of all ages.
by Lindsey Konkel
-
In the Moment- Spring 2017
Morgan Bolt, Esther Brandon, Randy Lopez.
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff